Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-23

FDA Approved: LOCAMETZ — Original Application (Advanced Accelerator Applications USA, Inc)

View source ↗

Summary

The FDA approved LOCAMETZ as an original application for a kit that prepares Gallium-68 gozetotide for PET imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOCAMETZ (kit for the preparation of gallium-68 gozetotide)

Snippet

ORIG AP for LOCAMETZ (KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE)